MBCL-43. RECURRENT MEDULLOBLASTOMA – LONG-TERM SURVIVAL WITH A “MEMMAT” BASED ANTIANGIOGENIC APPROACH

INTRODUCTION: Patients with recurrent medulloblastoma have a poor prognosis with only around 8% of patients surviving at 5 years irrespective of salvage therapy used. We report on 29 patients from four institutions treated with a “MEMMAT” based antiangiogenic combination therapy. PATIENTS AND METHOD...

詳細記述

保存先:
書誌詳細
出版年:Neuro Oncol
主要な著者: Slavc, Irene, Peyrl, Andreas, Gojo, Johannes, Holm, Stefan, Blomgren, Klas, Sehested, Astrid M, Leblond, Pierre, Czech, Thomas
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2020
主題:
Medulloblastoma (Clinical)
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715695/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.516
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料